Work

Abstract 526: Leveraging germline genetics to predict the efficacy of repurposing approved cancer therapies for cancer prevention

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-526

Authors: Chibuzor F. Ogamba, Elio Riboli, James Yarmolinsky, Philip C. Haycock, Ruth C. Travis, Karl Smith-Byrne

Institutions: University of Oxford, Imperial College London, University of Bristol

Language: English

Topic: Genetic Associations and Epidemiology

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409691130

Cites:

Cited by:

Related to: 10